Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

NCT05144087 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.

NCT NCT05144087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
Lead sponsor
University Hospital Southampton NHS Foundation Trust
Phase
Observational
Overall status
Active, not recruiting
Start date
May 25, 2022
Completion date
November 30, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma; eosinophilic